業績,医療の質,急性心筋梗塞における結果に対する報酬
Seth W Glickman1, Fang-Shu Ou, Elizabeth R DeLong
1Center for Clinical and Genetic Economics, Duke University Medical Center, Durham, NC, USA.
JAMA
|June 7, 2007
まとめ
パフォーマンスのための報酬 (P4P) プログラムは,急性心筋梗塞のケアや,大規模なパイロット研究におけるアウトカムを有意に改善しませんでした. また,このイニシアチブは,非インセンティブケアプロセスに悪影響を与えないことも示されました.
科学分野:
- 医療サービス 研究 医療サービス
- 品質改善イニシアティブ 品質改善イニシアティブ
- 心血管医学 心血管医学
背景:
- パフォーマンスの報酬 (P4P) は,医療の質を高めるための戦略です.
- Medicare & Medicaid Services (CMS) のセンターは,急性心筋梗塞 (AMI) のケア指標を含む大規模なP4Pパイロットプロジェクトを2003年に開始しました.
研究 の 目的:
- P4PとAMIケアプロセスと成果の改善との関連性を評価する.
- P4Pが非インセンティブケアに及ぼす意図せぬ影響を特定する.
主な方法:
- 2003年7月から2006年6月までの105,383人のAMI患者の観察的,患者レベルの分析.
- 54のP4P参加病院と,CRUSADE品質改善イニシアチブ内の446の対照病院を比較しました.
- ACC/AHAのガイドラインによる治療法と入院死亡率の評価.
主要な成果:
- P4P病院での6つのP4P誘導療法 (アスピリン,禁煙) のうち2つの改善率がわずかに高かった (P=.04,P=.05).
- P4Pと対照群の間で,インセンティブ付きまたはインセンティブのない治療のための複合的な測定では,大きな違いはありません.
- P4Pサイト (P=.21) で観察された入院死亡率の漸進的な改善はありません.
結論:
- CMS P4Pプログラムは,AMIのケア品質またはアウトカムにおける有意なインクリメンタル改善と関連付けられませんでした.
- P4Pと非インセンティブケアプロセスの改善との間に有害な関連は見つかりませんでした.
- 品質改善におけるP4Pの最適な役割を定義するために,さらなる研究が必要である.
さらに関連する動画
関連する概念動画
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Myocarditis III: Medical Management
343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Angina V: Nursing Management
565
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
565
Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626


